SLXN — BIOMOTION SCIENCES ORDINARY SHARES (Healthcare >> Biotechnology)
SLXN FAQ
What is SLXN's ROE?
BIOMOTION SCIENCES ORDINARY SHARES reports a Return on Equity (ROE) of -4,436.43%.
What is SLXN's dividend yield?
BIOMOTION SCIENCES ORDINARY SHARES offers a dividend yield of 0.00%.
What is SLXN's Deepscope Quality Score?
Deepscope rates SLXN's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy SLXN?
Deepscope's AI Timing Score for SLXN is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does SLXN belong to?
BIOMOTION SCIENCES ORDINARY SHARES is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 4.96
Price
0.10
(2.06%)
Day Change
|
|
|---|
SLXN Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 38) nhưng Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt , ...
| Yếu tố Chất lượng |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 82 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 4.96 |
| PBV / Sector |
7.00 / 4.58
|
| Earning Per Share | -31.45 |
| PE / Sector |
N/A / 17.10
|
| PEG or PE/Growth / Sector |
N/A / 0.52
|
| Average 1M Daily Value |
9.26 M
|
| Average 1W Daily Value |
0.78 M
GREAT
|
| Yếu tố Kỹ thuật |
|
85% |
| Sức khỏe tài chính |
|
50% |
| Khả năng kiếm lợi nhuận |
|
37% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-05 09:11:52 |
| Symbol | SLXN |
| Name | BIOMOTION SCIENCES ORDINARY SHARES |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 0.42 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 2.04 / 8,655.90 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: The Goldyne Savad Inst. of Gene Therapy, Jerusalem, Israel, 9112001
Phone: 972 2 674 3430
Website: https://silexion.com
Sector: Healthcare >> Biotechnology
Description: Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google